Tampa, Florida, Jan. 30, 2018 – Lung Institute, a provider of cellular therapy therapy to patients with developing or developed COPD and under the medical management company Regenerative Medicine Solutions, today announced it has earned The Joint Commission’s Gold Seal of Approval® for Ambulatory Health Care Accreditation by demonstrating continuous compliance with its nationally recognized standards….
* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.
^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.
All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.
As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.
The Lung Institute takes patient privacy seriously. The law requires that our healthcare facilities and medical personnel protect the privacy of your medical record and other health information We are also required to notify you of our privacy practices with regard to your Protected Health Information. This Privacy & Security Notice explains how your medical information is protected under HIPAA and HITECH laws and how your information may be used, disclosed, and accessed.
Internet Privacy Disclosure
The Information We Collect: The Lung Institute collects information by various methods including information actively provided by its lead providers, customers and information arising from customer surveys and general feedback. The types of personal information we collect include name, contact information, identification information, credit information and other data types as appropriate. Credit card information is used for billing purposes only.
We may record calls to or from our patient coordinators/customer service representatives for purposes of accuracy, performance reviews, training and general quality assurance.
How We Use This Information: This information is used to aid in the provision of our various products and services, including customer service, accounting, billing, collections and the marketing of other products and services. The Lung Institute may use aggregate or anonymous information for various uses for itself and third parties.
Who We Share This Information With: The Lung Institute does not share personal information with any third parties except as disclosed in this policy. The Lung Institute may provide personal information to the Lung Institute's subcontractors and professional advisers (which shall be bound by privacy obligations) to assist the Lung Institute's uses disclosed herein.
Security Personal information is stored in a combination of paper and electronic files. They are protected by security measures appropriate to the nature of the information.
Accessing Information: Individuals may review their personal information contained in the Lung Institute's files by contacting the Lung Institute's privacy officer. If an individual believes that any of their personal information is inaccurate, we will make appropriate corrections.
Telephone Numbers and Calls: By providing your telephone number to the Lung Institute on this contact form, you acknowledge and agree that you may receive a telephone call from the Lung Institute, at the number you provided on the online form, to receive information regarding the treatments offered at the Lung Institute. Such telephone calls may be placed by an automatic telephone dialing system and/or may contain prerecorded messages. By providing your mobile number to the Lung Institute, you further acknowledge and agree that you may receive text messages (SMS) from the Lung Institute at the number you provided to the Lung Institute. Protected Health Information will not be requested by the Lung Institute, if you choose to respond with Protected Health Information you agree to release the Lung Institute from any liability related to such disclosure. Be advised that any telephone calls and/or text messages are strictly informational and/or transactional in nature. the Lung Institute therefore does not accept liability for any errors or omissions in the contents of email messages, or any responding emails that contain confidential patient information, which arise as a result of email transmission. This statement is required by Electronic Communications Privacy Act, 18 U.S.C. Sections 2510-2521
General:The Lung Institute may amend this policy from time to time. If such amendments affect how the Lung Institute uses or discloses personal information already held by the Lung Institute in a material way, the Lung Institute will obtain consent.
Notwithstanding the general terms of this policy, the collection, use, and disclosure of personal information may be made outside of the terms herein to the extent provided for in any applicable privacy or other legislation in effect from time to time.
The Lung Institute may disclose personal information to another entity purchasing (including for diligence purposes prior to purchase) the assets of the Lung Institute, provided that entity abide